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Cysteine proteinases expressed by schistosomes appear to play key roles in the digestion of host hemoglobin,
the principal source of amino acid nutrients utilized by these parasites. We have shown previously that the
predominant cysteine proteinase activity in soluble extracts and excretory/secretory (ES) products of adults of
Schistosoma mansoni and S. japonicum is cathepsin L-like in its substrate specificity. However, biochemical
analysis of the cathepsin L activity in extracts and ES products of schistosomes has been complicated by the
presence of at least two distinct forms of schistosome cathepsin L, termed SmCL1 and SmCL2. We now report
the purification and enzyme characteristics of active, recombinant SmCL1 which was obtained by transforming
Saccharomyces cerevisiae with an expression plasmid encoding the preproenzyme of SmCL1. Recombinant
SmCL1 was secreted by the transformed yeast into the culture media from which it was purified by gel filtration
and ion-exchange chromatography. The purified enzyme exhibited substrate specificity against synthetic
peptidyl substrates (e.g., Boc-Val-Leu-Lys-NHMec and Z-Phe-Arg-NHMec; kcat/Km 5 17.25 and 6.24 mM
21
s21, respectively) and against gelatin and hemoglobin, characteristic of cathepsin L. Immunoblot analysis
using antiserum raised against recombinant SmCL1 demonstrated that native SmCL1 of 33 kDa was present
in ES products and soluble extracts of S. mansoni. Using this antiserum and thin tissue sections, we localized
the native SmCL1 to the gastrodermis and to the tegument of adult schistosomes. Recombinant SmCL1 was
capable of degrading human hemoglobin at pH 4.0 to 4.5 but not higher, suggesting that denaturation of
hemoglobin by low pH, as found in the cecum of the adult schistosome, may be necessary for its catalysis by
cathepsin L and other gut-associated proteinases. Together, these results support a role for SmCL1 in the
degradation of host hemoglobin within the gut of the schistosome.
Schistosomiasis afflicts more than 250 million people in trop-
ical and subtropical regions. The disease is caused by blood
flukes of the genus Schistosoma, and infection is acquired in
contaminated water, where cercariae penetrate the skin. After
migrating through the lungs and liver, the developing Schisto-
soma japonicum and S. mansoni parasites take up residence in
the mesenteric veins, where male and female worms mature
and reproduce. Each day, female schistosomes produce nu-
merous eggs which move through the intestinal wall into the
lumen of the bowel and are shed with the feces. The pathology
associated with schistosomiasis caused by S. japonica and S.
mansoni is primarily a consequence of inflammatory responses
to eggs inadvertently carried to the liver and other sites (17).
Cysteine proteinases, including cathepsin L-like and cathep-
sin B-like proteinases, are considered important targets to
which novel antischistosome chemotherapy and/or immuno-
prophylaxis could be directed (4, 9, 18). These enzymes appear
to be involved in the degradation of host hemoglobin, the main
source of nutrient used by schistosomules and adult worms (8,
14). Both activities are secreted by adult schistosomes (7), and
tissue localization studies have indicated their presence in the
gastrodermal cells lining the cecum of the parasite (25). Inhib-
itors of cysteine proteinases were shown to prevent hemoglo-
bin digestion by schistosomula and decrease their viability in
vitro (23, 25). Moreover, treatment of S. mansoni-infected
mice with these inhibitors not only reduced worm burden but
exhibited antifecundity effects (23).
Elucidation of the precise physiological role of the cathepsin
L-like and cathepsin B-like proteinases of schistosomes has
been hampered by the difficulty of obtaining homogeneous
enzymes. The enzymes have similar molecular sizes and sub-
strate specificities, and past biochemical studies appear to have
been performed on enzyme mixtures (4). Furthermore, we and
others have shown that schistosomes express at least two dis-
tinct cathepsin L proteinases, termed S. mansoni cathepsin L1
(SmCL1) and SmCL2 (10, 19, 21). Michel et al. have demon-
strated that SmCL2 is expressed in the reproductive organs of
S. mansoni (19), and thus we consider that it is unlikely to play
a role in hemoglobin degradation in the gastrodermis or cecum
of the schistosome.
We have recently described a system for obtaining function-
ally active cathepsin L proteinases of the digenean trematode
Fasciola hepatica by expressing cDNAs encoding preproca-
thepsin L in the brewer’s yeast, Saccharomyces cerevisiae (12,
20). The recombinant F. hepatica proteinases were produced
and processed by the yeast to their mature forms, thereby
obviating the need for protein refolding and/or activation
steps. Using the same approach, we now report the recombi-
nant expression of SmCL1 cDNA (21). We purified recombi-
nant SmCL1 from yeast culture supernatants and character-
ized its activity against a panel of synthetic substrates, gelatin,
and human hemoglobin. Immunolocalization studies using an-
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tiserum raised against recombinant SmCL1 showed that native
SmCL1 was present in the gastrodermal cells lining the cecum
of adult worms and at other sites, and immunoblotting studies
detected the enzyme in excretory/secretory (ES) products. To-
gether, these results support a role for SmCL1 in the degra-
dation of host hemoglobin within the gut of the schistosome.
MATERIALS AND METHODS
Synthetic peptidyl substrates and inhibitors. Boc-Val-Leu-Lys-NHMec (Boc,
t-butyloxycarbonyl; NHMec, 7-amino-4-methyl coumarin), benzyloxycarbonyl
(Z)-Phe-Ala-diazomethylketone (CHN2), 1-3-carboxy-2-3-trans-epoxypropionyl-
leucylamido(4-guanido)-butane (E-64), dithiothreitol, and L-cysteine were ob-
tained from Sigma Chemical Co. Z-Phe-Arg-NHMec, Z-Phe-Val-Arg-NHMec,
Z-Arg-Arg-NHMec, Z-Arg-NHMec, and tosyl (Tos)-Gly-Pro-Arg-NHMec were
purchased from Bachem.
Schistosome extracts. Soluble extracts of S. mansoni cercariae, separate-sex
adults, and media containing cysteine proteinases secreted by cultured adult
worms (ES products) were prepared as previously described (7, 8).
Cloning of SmCL1 and yeast expression plasmid construction. Isolation and
characterization of the cDNA encoding the complete preprocathepsin SmCL1
(GenBank accession no. U07345) have been described previously (10, 21). The
cDNA encoding the SmCL1 prepro enzyme was amplified by PCR using two
primers designed to anneal to the 59 and 39 termini of the cDNA: SmCL1F
(CGCAAGCTTATGCCTGTAAACCTCGAGTAC) and SmCL1R (CGCAAG
CTTCCCCTAGTAGATCATCGCTGA). The primers included HindIII rec-
ognition sequences (underlined). The amplified fragments were cloned into
pGemT (Promega). (Nucleotide sequencing of the recombinant plasmid verified
that the sequence had not been mutated during the PCR.) The plasmid insert
was excised with HindIII and ligated into the yeast expression plasmid pAAH5
(1, 20) (kindly provided by J. R. Dickinson, University of Wales, Cardiff, United
Kingdom), linearized with HindIII. pAAH5 is a shuttle vector with the yeast
replication region of the 2mm circle and the Escherichia coli replication region of
pBR322. The HindIII cloning site is flanked at the 59 side by the promoter and
the untranslated leader of the yeast alcohol dehydrogenase gene ADC1 contain-
ing the ribosome-binding site (1). The SmCL1 insert provided the translation and
termination codons. The signals required for posttranslational processing and
intracellular sorting of the proenzyme are encoded by the prosegment-encoding
sequences within the SmCL1 gene (7, 10, 21). An internal EcoRI site within the
SmCL1 cDNA was used to determine the correct orientation of the SmCL1
insert within the vector. A clone with the correct orientation for expression was
isolated and named pAAH5.SmCL1. E. coli MC1061 was used for propagating
pAAH5 and recombinant constructs.
Transformation and culturing of S. cerevisiae. S. cerevisiae DBY746 (Mata
his3-D1-leu2-3 leu2-112 ura3-52 trp1-289a) (Yeast Genetic Stock Center, Depart-
ment of Biophysics and Medical Physics, University of California, Berkeley) was
routinely maintained in complex medium (YEPD); 10 g of yeast extract, 20 g of
peptone, and 20 g of D-glucose per liter). S. cerevisiae cells were transformed with
pAAH5.SmCL1 in the presence of lithium acetate (6). Yeast transformants were
cultured in selective minimal medium (6.7 g of Bacto Yeast Nitrogen Base
[lacking leucine but containing histidine and tryptophan; Difco], 10 g of D-
glucose, and 20 mg of uracil, per liter in 0.1 M sodium citrate, pH 5.5). (The
selection marker on pAAH5 is Leu2 [1].) For expression of recombinant yeast-
expressed SmCL1 (ySmCL1), yeast cells were grown in an automative fermentor
(New Brunswick model 101) in selective minimal medium at 30°C until the
optical density at 600 nm reached 1.4. Yeast cells were removed by centrifuga-
tion, and the supernatant was stored at 4°C.
Purification of ySmCL1. Five liters of pAAH5.SmCL1-transformed yeast su-
pernatant was concentrated at 4°C to 20 ml in an Amicon 2000A concentrator,
using an Amicon YM3 membrane (3,000-Da molecular mass cutoff). The con-
centrate was applied to a Sephacryl S200 HR (Pharmacia) gel filtration column
(2.6 by 74.5 cm) equilibrated in 0.1 M Tris-HCl (pH 7.0) at 4°C. Proteins were
eluted from the matrix with 0.1 M Tris-HCl (pH 7.0), and fractions (5 ml)
containing cathepsin L activity, measured by using the fluorogenic substrate
Z-Phe-Arg-NHMec (see below), were pooled. The pooled fractions were con-
centrated to 3 ml, dialyzed against 20 mM Tris-HCl (pH 7.0), and applied to a
QAE-Sephadex A50 column (10 cm by 2.5 cm; Pharmacia), equilibrated in the
same buffer. The column was washed with the equilibration buffer (375 ml), after
which bound molecules were eluted on a 0 to 500 mM NaCl gradient. Fractions
(5 ml) containing cathepsin L activity were pooled, concentrated as described
above, and stored at 220°C.
Characterization of ySmCL1 proteinase activity. Cathepsin L proteinase ac-
tivity was characterized by using peptidyl-NHMec as substrates (below). These
substrates were stored as a 1-mg/100-ml stock solution in dimethylformamide.
Assays were carried out with a final concentration of 10 mM substrate in 0.1 M
sodium phosphate buffer, pH 6.5, containing 1 mM dithiothreitol, in a volume of
1 ml. The solutions were incubated at 37°C for 1 h before the reaction was
terminated by the addition of 0.2 ml of 1.7 M acetic acid. The amount of NHMec
released was measured with a fluorimeter (370-nm excitation and 440-nm emis-
sion). One unit of enzyme activity was defined as that amount which catalyzed
the release of 1 mmol of NHMec/min at 37°C.
Substrate specificity and kinetics of purified ySmCL1 were determined with
the peptide substrates Z-Phe-Arg-NHMec, Z-Phe-Val-Arg-NHMec, Z-Arg-Arg-
NHMec, Z-Arg-NHMec, Z-Gly-Pro-Arg-NHMec, and Boc-Val-Leu-Lys-NHMec.
The kinetic constants, kcat and Km were obtained by nonlinear regression analysis
using the Enzfitter program (15). Active-site titration using the cysteine protein-
ase inhibitor E-64 and the fluorogenic substrate Z-Phe-Arg-NHMec was per-
formed to determine the molar concentration of active ySmCL1, using the
method of Barrett et al. (2). For determination of the optimum pH of proteinase
activity, the following buffers were used at a concentration of 50 mM: glycine, pH
2.5 to 3.0 and 9.1 to 10.0; sodium acetate, pH 3.5 to 5.5; sodium phosphate, pH
5.5 to 7.5; and Tris-HCl, pH 7.5 to 9.0. The ionic strength of each buffer was
equalized to 100 mM by using NaCl.
Expression of recombinant SmCL1 in E. coli and preparation of rabbit anti-
SmCL1 serum. A cDNA encoding the mature SmCL1 was ligated into the E. coli
expression vector pQE30 (Qiagen, Chatsworth, Calif.) and used to transform E.
coli M15 as previously described by Dalton et al. (7). LB medium containing
ampicillin (100 mg/ml) and kanamycin (25 mg/ml) was inoculated with trans-
formed cells and incubated at 37°C with shaking until the optical density at 600
nm reached 0.8. Expression of recombinant bacterium-expressed SmCL1
(bSmCL1) was induced by addition of isopropyl-1-thio-b-D-galactopyranoside to
1 mM, and the cells were harvested 5 h later by centrifugation. The cell pellet was
resuspended in 0.1 M sodium phosphate–0.01 M Tris-HCl (pH 8.0) containing 6
M guanidine hydrochloride at 5 ml per g of cell pellet and sonicated for 8 min
(duty cycle, 25%; output, 2.5) (Branson Sonifier 250; Branson Ultrasonics) to
disrupt bacterial cells. The extract was centrifuged at 14,000 3 g for 30 min, and
the supernatant was incubated with 2 ml of Ni-nitrilotriacetic acid (NTA) Su-
perflow resin (Qiagen) for 1 h at room temperature. The resin was packed into
a column and washed with 5 volumes of 0.1 M sodium phosphate–0.01 M
Tris-HCl (pH 7.2) containing 8 M urea. Recombinant bSmCL1 was eluted with
a linear gradient of imidazole, prepared at 250 mM in the last buffer, at 0.5
ml/min over 50 ml. One-milliliter fractions were collected and analyzed by so-
dium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and im-
munoblotting with a monoclonal antibody specific for the R-G-S-H-H-H-H
epitope (Qiagen) engineered onto the C terminus of the recombinant protein
expressed in pQE30. Purified bSmCL1 was used as antigen to raise an anti-
bSmCL1 serum in a New Zealand White rabbit. The rabbit was immunized five
times with 20 mg of bSmCL1 in QuilA adjuvant (Superfos Biosector, Fred-
erikssund, Denmark) with intervals of 3 weeks between boosts. Antibodies in the
serum of these immunized rabbits reacted with recombinant SmCL1 but not
SmCL2 in immunoblotting experiments (data not shown).
SDS-PAGE analysis, zymography, immunoblotting, and glycosylation studies.
Native and recombinant schistosome proteins were analyzed by SDS-PAGE
(12% gel) under reducing conditions as described by Dalton et al. (7). Both
zymographic analysis using gels containing copolymerized gelatin and immuno-
blotting were performed with anti-bSmCL1 serum as previously described (7, 10,
11, 22). Glycoproteins were detected by using a DIG Glycan detection kit
(Boehringer, Mannheim, Germany) in which transferrin and creatinase were
used as positive and negative controls, respectively. Protein concentrations were
measured by using a DC protein assay kit from Bio-Rad.
Hemoglobin proteolysis. Hemoglobin was prepared as described previously
(3). Hemoglobin (150 mg) was incubated with ySmCL1 (20 mg) at 37°C for 18 h
in the presence of 1 mM dithiothreitol. Digestions were carried out in the
following buffers: 0.1 M sodium acetate, pH 4.0 and 4.5; 0.1 M sodium citrate, pH
5.0 and 5.5; and 0.1 M sodium phosphate, pH 6.0 and 6.5. The ionic strength of
each buffer was equalized to 100 mM by using NaCl. Following the incubation,
the reaction products were analyzed by SDS-PAGE (15% gel) under nonreduc-
ing conditions and staining with Coomassie brilliant blue R250.
Immunolocalization of SmCL1 in adult worms. Mixed-sex adult worms were
perfused from mice and then embedded in Tissue-Tek O.C.T. medium (Sakura
Finetek, Torrance, Calif.), after which 10-mm sections were cut with a cryostat
microtome. The sections were mounted on glass slides and air dried for 4 h.
Sections were fixed in ice-cold acetone for 2 min, washed in phosphate-buffered
saline (PBS), and incubated in goat normal serum diluted 1:5 in PBS for 30 min
to inhibit nonspecific background with the secondary antibody (below). After
being washed in PBS, sections were incubated in rabbit anti-bSmCL1 or control
(preimmunization) serum diluted 1:20 in PBS–1% bovine serum albumin for 1 h.
Sections were washed in PBS and incubated in goat anti-rabbit IgG conjugated
to fluorescein isothiocyanate (Calbiochem, La Jolla, Calif.) diluted 1:100 in
PBS–1% bovine serum albumin. (The conjugated antibody had been pread-
sorbed to bovine, horse, human, and mouse sera by the manufacturer.) All
incubations were performed at room temperature. After further washing in PBS,
sections were mounted in Crystal/Mount medium (Biomeda, Foster City, Calif.),
viewed under UV light on an Olympus BX60 microscope, and photographed.
RESULTS
Recombinant SmCL1 expressed in yeast and bacteria. Ten
positive yeast clones transformed with pAAH5.SmCL1 were
selected and tested for secretion of proteinase activity into
culture media with Z-Phe-Arg-NHMec as the substrate (see
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below). All 10 secreted proteinase at similar levels, but the
clone producing most enzyme activity was used for subsequent
fermentations. By contrast, medium in which yeast trans-
formed with nonrecombinant pAAH5 were cultured did not
contain Z-Phe-Arg-NHMec-cleaving activity (data not shown).
The concentrate from a 5-liter fermentation using the positive
clone (above) exhibited potent activity against Z-Phe-Arg-
NHMec. This activity was enhanced by dithiothreitol and com-
pletely blocked by E-64 (5 mM) and by the cathepsin L and
cathepsin B-specific inhibitor Z-Phe-Ala-CHN2 (5 mM) (data
not shown). These results showed that the pAAH5.SmCL1-
transformed yeast secreted cathepsin L-like cysteine protein-
ase activity. The specific activity of this proteinase in the cul-
ture supernatant was 0.06 U/mg of protein (Table 1).
The mature form of SmCL1 expressed in E. coli was isolated
from inclusion bodies under denaturing conditions by affinity
chromatography on nickel chelate (Ni-NTA) resin. SDS-
PAGE analysis indicated that a protein which migrated at ;24
kDa was eluted from the Ni-NTA resin and was .90% homo-
geneous (data not shown). The recombinant protein reacted
strongly on immunoblots with the monoclonal antibody to the
polyhistidine ligand (not shown), demonstrating, based on this
reactivity and its predicted size of 24 kDa, that it was the
recombinant, mature form of SmCL1 (not shown). Recombi-
nant bSmCL1 was used as the antigen to prepare a monospe-
cific rabbit antiserum to SmCL1, which strongly recognized
bSmCL1 at a dilution of 1:2,000 in immunoblots (not shown).
Purification of ySmCL1. ySmCL1 was purified from yeast
culture media by gel filtration followed by ion-exchange chro-
matography. Z-Phe-Arg-NHMec-cleaving activity resolved as
two peaks on the S200 HR matrix. Fractions corresponding to
both peaks were separately pooled. Although the total activity
was greater in the first peak (peak I) than in the second peak
(peak II), further purification was performed with the enzyme
pool of peak II since it contained proteinase with much higher
specific activity (peak I, 0.169 U/mg; peak II, 0.552 U/mg)
(Table 1). When the peak II activity was applied to the ion-
exchange QAE-Sephadex matrix, the majority of the proteo-
lytic activity failed to bind to the resin and was collected in the
run-through fractions. Little proteolytic activity was subse-
quently eluted on the NaCl gradient (data not shown). The
proteinase in the run-through from QAE-Sephadex exhibited a
specific activity of 2.5 U/mg, which represented a 42-fold en-
richment compared to the fermentation supernatant (Table 1).
We divided the run-through into three pools based on elu-
tion time from QAE-Sephadex and then examined the protein
profile of the pools, along with the concentrated culture media,
and peak II from S200 HR by Coomassie staining after SDS-
PAGE (Fig. 1A). The gel demonstrated that we had enriched
a protein of 45 kDa close to purity (Fig. 1A, lane 5) on the gel
filtration followed by anion-exchange resins. Immunoblot anal-
ysis of the same preparations demonstrated that this 45-kDa
protein reacted very strongly on immunoblots with the anti-
bSmCL1 serum but did not react with control (preimmuniza-
tion) serum, verifying its identity as recombinant SmCL1 (Fig.
1B and C). This preparation (Fig. 1A, lane 5) was used for the
characterization of ySmCL1 detailed below.
The molecular size of ySmCL1 was greater than the size
predicted for the mature SmCL1 (24.1 kDa) or the proenzyme
(35 kDa) (21). Since the SmCL1 sequence contains three po-
tential N-linked glycosylation sites, the purified protein was
tested for the presence of N-linked sugar residues by using an
enzyme immunoassay-based glycan detection system. The re-
combinant protein showed a positive reaction for the presence
FIG. 1. Chromatographic purification of ySmCL1 on gel filtration and anion-exchange matrices. Ten to 20 mg of protein of concentrated culture medium (lane 1),
S200 HR peak II (lane 2), and QAE-Sephadex run-through pool I (lane 3), pool II (lane 4), and pool III (lane 5) were separated by SDS-PAGE (12% gel) under
reducing conditions. Gels were either stained with Coomassie brilliant blue R (A) or transferred to nitrocellulose and probed with rabbit anti-bSmCL1 serum (B) or
control serum (C).
TABLE 1. Chromatographic purification of recombinant ySmCL1
on gel filtration and ion-exchange matrices
Prepn Protein(mg)
Activity
(U)
Sp act
(U/mg)
Yield
(%)
Purification
(fold)
Culture medium 53.1 3.24 0.06 100 1
S200 HR
Peak I 12.52 2.12 0.169 65.4 2.82
Peak II 2.03 1.12 0.552 34.6 30.2
QAE-Sepadex poola 0.18 0.45 2.5 14.0 42.0
a Only proteinase activity in the S200 HR peak II was applied to the QAE-
Sephadex column.
TABLE 2. Reaction kinetics of recombinant ySmCL1 on
peptide substrates
Substrate Km(mM)
kcat
(s21)
kcat/Km
(mM21 s21)
Z-Phe-Arg-NHMec 8.5 0.053 6.24
Boc-Val-Leu-Lys-NHMec 10.2 0.176 17.25
Z-Phe-Val-Arg-NHMec 9.8 0.02 1.32
Tos-Gly-Pro-Arg-NHMec 15.1 0.04 2.72
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of glucan (data not shown). Glycosylation of ySmCL1 may
explain its slow migration on gels.
Purified ySmCL1 and soluble extracts of adult S. mansoni
were analyzed for cysteine proteinase activity by gelatin-sub-
strate PAGE under native conditions. Two prominent gela-
tinolytic bands were observed in extracts of adult S. mansoni
parasites but were apparent only under reducing conditions
when the gels were incubated in the presence of cysteine (Fig.
2A). We have previously attributed these activities in schisto-
some extracts to cathepsin L-like cysteine proteinases (7, 10).
The proteinases are known to be also expressed by S. mansoni
cercariae and schistosomules and to occur in ES products from
cultures of adult schistosomes (7, 8). ySmCL1 resolved as a
single band which migrated more slowly than the two protein-
ases in the schistosome extracts. The slower migration may be
due to hyperglycosylation, as discussed above. Like the activi-
ties in the schistosome extracts, activity of ySmCL1 was en-
hanced markedly by the reducing agent, cysteine (Fig. 2B). By
contrast, extracts and supernatants of nontransformed yeast
did not exhibit gelatinolytic activity (data not shown). The
optimum pH for the gelatinolytic activity of ySmCL1 was pH
6.5 (data not shown).
Activity of ySmCL1 against synthetic peptides and hemoglo-
bin. The substrate specificity of the ySmCL1 was characterized
by using fluorogenic peptide substrates (Table 2). Initial stud-
ies showed that the enzyme efficiently cleaved the cathepsin L-
and cathepsin B-specific substrate Z-Phe-Arg-NHMec but ex-
hibited minimal activity against Z-Arg-Arg-NHMec, a sub-
strate diagnostic of cathepsin B, and against Z-Arg-NHMec, a
cathepsin B and cathepsin H substrate (not shown). Analysis of
reaction kinetics demonstrated that the enzyme cleaved Boc-
Val-Leu-Lys-NHMec with greater efficiency (kcat/Km) than
any of the other substrates examined, including Z-Phe-Arg-
NHMec (Table 2). This observation is consistent with our
earlier report of the substrate specificity of cathepsin L-like
activity in soluble extracts of schistosomes (7–10, 21). In com-
parison to Z-Phe-Arg-NHMec, Z-Phe-Val-Arg-NHMec, a
substrate diagnostic of cathepsin S, was cleaved much less
efficiently by recombinant SmCL1. ySmCL1 also cleaved Tos-
Gly-Pro-Arg-NHMec, a substrate which we have shown can dis-
FIG. 2. Gelatinolytic activity of ySmCL1. Soluble extracts of adult S. mansoni
(A) and ySmCL1 (B) were analyzed by 10% gelatin-substrate PAGE (zymogra-
phy) at pH 6.5 in the presence (lanes 1) and absence (lanes 2) of 10 mM cysteine.
FIG. 3. pH profile of activities of ySmCL1 against peptide substrates. The
activities of ySmCL1 against Z-Phe-Arg-NHMec (Z-F-R-NHMec) and Z-Val-
Leu-Lys-NHMec (Z-V-L-K-NHMec) were measured at different pHs. Points
represent the means of duplicate experiments and are plotted as relative activity.
FIG. 4. Hydrolysis of native human hemoglobin by ySmCL1. Native human
hemoglobin was incubated with (1) and without (2) purified ySmCL1. Reac-
tions were carried out at 37°C, at different pHs and in the presence of 1 mM
dithiothreitol. After incubation for 18 h, the reaction products were resolved by
SDS-PAGE (15% gel) under nonreducing conditions, and the gels were stained
with Coomassie blue.
FIG. 5. Immunoblot analysis of S. mansoni soluble extracts and ES products.
Extracts of adult male schistosomes (lane 1), adult females (lane 2), mixed-sex
cercariae (lane 3), and ES products from mixed-sex adults (lane 4) were sepa-
rated by SDS-PAGE, transferred to nitrocellulose, and probed with anti-
bSmCL1 serum. Replicate filters probed with control (preimmunization) serum
showed no reactivity (data not shown).
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tinguish different classes of F. hepatica cathepsin L (11, 12, 20, 22),
although the efficiency of cleavage was not as high as reported for
F. hepatica cathepsin L2 (11, 12). ySmCL1 exhibited activity over
a wide pH range (pH 3.5 to 10.0), although it exhibited a pH
optimum for activity of 6.5 against the peptide substrates Z-Phe-
Arg-NHMec and Boc-Val-Leu-Lys-NHMec (Fig. 3).
ySmCL1 cleaved human hemoglobin and, based on the
smeared appearance of the digested products, cleaved this sub-
strate at more than one site. In contrast to peptide substrates and
gelatin, where it showed a pH optimum for activity of pH 6.5,
ySmCL1 most efficiently cleaved hemoglobin at pH 4.5. Indeed,
hemoglobin was not digested at pH 5.0 or above (Fig. 4).
Identification of native SmCL1 in soluble extracts and ES
products of schistosomes. Soluble extracts of female and male
adults, cercariae, and ES products of S. mansoni were sepa-
rated by SDS-PAGE (12% gel), transferred to nitrocellulose,
and probed with rabbit anti-bSmCL1 serum. Each lane was
loaded with 10 mg of protein. We identified in the male and
female adult S. mansoni extracts and ES products an antigen of
;33 kDa that appeared to represent mature, native SmCL1
(Fig. 5). Based on the intensity of the signal, this protein was
present at a higher concentration in female than male extract.
We identified in male, female, and cercarial extracts a second
antigen of ;43 kDa that likely represents the proenzyme form
of SmCL1. Also evident were several weakly staining bands of
40 to 35 kDa, possibly breakdown products or differentially
glycosylated isoforms of SmCL1. The 33-kDa band was very
prominent in ES products, whereas the 43-kDa band was not
present, indicating that SmCL1 is processed to its active form
before being secreted into the gut. No bands were visualized on
replicate blots probed with the control (preimmunization) rab-
bit serum (not shown).
Immunolocalization of native SmCL1 in adult worms. Using
rabbit preimmunization and anti-bSmCL1 sera, we probed thin
sections of adult male and female S. mansoni to determine the
site of expression and/or activity of SmCL1. A series of 10-mm-
thick longitudinal, diagonal, and transverse sections were ex-
amined by light microscopy. No specific reactivity was observed
on sections probed with preimmunization serum (Fig. 6A). By
contrast, immunofluorescent labeling was observed on sections
probed with anti-bSmCL1 serum (i) at the tegument of adult
worms of both sexes, with more prominent reactivity at and
immediately below the tegument on the ventral surface of male
worms (Fig. 6B), and (ii) in the gastrodermal cells lining the
lumen of the schistosome gut (Fig. 6C). No reactivity was
evident at other sites or organs in the adult worms.
DISCUSSION
Given the difficulty in obtaining large numbers of schisto-
somes, it is not practical to isolate the enzymes directly from
schistosomes for analysis of their biochemical activities or
physiological roles. cDNAs encoding two discrete forms of
cathepsin L from adult S. mansoni (SmCL1 and SmCL2) and
adult S. japonicum (SjCL1 and SjCL2) have been reported (10,
19, 21). In a previous attempt to obtain functionally active
schistosome cathepsins, we expressed the cognate S. mansoni
cDNAs in E. coli; unfortunately, the recombinant proteins
were compartmentalized by the bacteria into inclusion bodies
from which we have been unable to isolate correctly folded,
active proteinases (7). Accordingly, we have now used a eu-
karyotic expression system, S. cerevisiae transformed with the
expression plasmid pAAH5. (We have successfully used this
system to produce substantial quantities of each of two forms
of cathepsin L from the related trematode parasite F. hepatica
[12, 20]). By transforming yeast with pAAH5 encoding the full
preproenzyme sequence of SmCL1, we obtained functional
expression of active, recombinant schistosome cathepsin L.
Manipulations to denature, refold, and activate the recombi-
nant enzyme were not necessary.
Purification of ySmCL1 from the culture medium was
achieved by using gel filtration followed by ion-exchange chro-
matography. The enzyme resolved as two peaks in gel filtration
chromatography, although we subjected only the second peak,
which contained the enzyme in higher specific activity, to pu-
rification by ion-exchange chromatography. The exclusion of
the first peak resulted in loss of the much of the available
enzyme, as it contained 65% of the total proteolytic activity.
We observed a similar elution profile of F. hepatica cathepsin
L proteinases on gel filtration, where it appears that aggrega-
tion of the recombinant enzyme to yeast proteins causes the
protein to resolve in separate peaks (12, 20). Nevertheless, we
obtained from a 5-liter fermentation sufficient ySmCL1 for
analysis of the substrate specificity, enzyme kinetics, and he-
moglobinolysis studies.
ySmCL1 exhibited a molecular size of 45 kDa, greater than
the predicted sizes for the mature enzyme (24.1 kDa) and the
proenzyme (35 kDa) (21). Glycosylation of ySmCL1 by the
yeast cells may have contributed to its retarded migration in
gels. Mature SmCL1 has three potential glycosylation sites (7,
21), and S. cerevisiae is known to hyperglycosylate recombinant
proteins (5). The molecular sizes for the native schistosome
SmCL1 (33 kDa) and the proenzyme (43 kDa), identified in
immunoblots, are also greater than the predicted sizes, which
may indicate that the enzymes are naturally glycosylated. Hy-
perglycosylation by yeast can result in an inactive recombinant
protein; to avoid this problem, Lipps et al. (16) used a mutant
cathepsin B Sm31 cDNA from which glycosylation sites had
been deleted. Notwithstanding these mutations, the yeast-ex-
pressed recombinant cathepsin B required exogenous pepsin
for its activation. By contrast, ySmCL1 was enzymatically ac-
tive, and its activity was enhanced at acidic pH and by reducing
conditions, as expected for a cathepsin L cysteine proteinase.
The activity was also completely inhibited by the general cys-
teine proteinase inhibitor E-64 as well as the specific cathepsin
L inhibitor Z-Phe-Ala-CHN2.
Kinetic studies showed that ySmCL1 preferred substrates
with a hydrophobic residue in the P2 position, including Boc-
Val-Leu-Lys-NHMec and Z-Phe-Arg-NHMec. By contrast,
the enzyme showed minimal activity toward the cathepsin B
substrates Z-Arg-NHMec and Z-Arg-Arg-NHMec. It is note-
worthy that, and consistent with our earlier findings on the
cathepsin L-like activities in extracts and ES products of schis-
tosomes (7, 10), ySmCL1 exhibited a marked preference for
Boc-Val-Leu-Lys-NHMec over Z-Phe-Arg-NHMec. Earlier
studies by Dowd et al. (11, 12) showed that purified cathepsin
L’s from the related trematode F. hepatica have a similar sub-
strate preference for Boc-Val-Leu-Lys-NHMec. The presence
FIG. 6. Immunolocalization of native SmCL1 in adult schistosomes. Longitudinal sections of male worms were probed with preimmunization (A; scale bar 5 5 mm)
or rabbit anti-bSmCL1 (B; scale bar 5 10 mm) serum followed by labeling with anti-rabbit antibody-fluorescein conjugate. No specific labeling was observed with
preimmunization serum (A), but intense labeling was observed in the tegument, particularly on the ventral surface, with anti-bSmCL1 (B). Labeling was also observed
with anti-bSmCL1 in the gastrodermal cells lining the gut, as shown in the transverse sections of female adult worms (C; scale bar 5 2.5 mm). VT, ventral tegument;
DT, doral tegument; P, parenchyma; LU, gut lumen; GA, gastrodermis.
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of an additional residue in the P3 position, Val in this case, may
increase the overall binding energy of the substrate in the
active site of the enzyme, resulting in more efficient hydrolysis.
Nevertheless, these observations indicate that Boc-Val-Leu-
Lys-NHMec may be a more sensitive substrate for measuring
cathepsin L-like activity in helminth parasites than Z-Phe-Arg-
NHMec, which has classically been used to demonstrate ca-
thepsin L in mammalian tissues (2).
ySmCL1 showed higher pH optima for activity against gel-
atin and synthetic peptidyl substrates than for hemoglobin.
While ySmCL1 was most active against Boc-Val-Leu-Lys-
NHMec at pH 6.5, it was inactive against hemoglobin at pH 5.0
and higher. This finding indicates that denaturation of the
hemoglobin by acidic pH may be required before it can be
digested by SmCL1, and this may reflect the physicochemical
environment of the schistosome gut, which appears to be acidic
(4). Earlier studies by us and others showed that both cathep-
sin L- and cathepsin D-like proteinases were secreted by adult
S. mansoni and that both enzymes were involved in the degra-
dation of hemoglobin (3, 7, 13). The present results demon-
strating the presence of SmCL1 in the gastrodermal cells lining
the gut (at higher levels in female than in male parasites), its
presence in ES products, and its ability to digest hemoglobin at
acidic pH signal the probable biological function of this schis-
tosome cathepsin. Together, they indicate that SmCL1 plays a
role in proteolysis of hemoglobin within the schistosome gut. If
this is so, SmCL1 has a role discrete from that of SmCL2,
which is located in the reproductive organs (19). It is notewor-
thy that SmCL1 is located in the tegument of male schisto-
somes in addition to the digestive tract. Other enzymes, such as
schistosome legumain and cathepsin D, that are associated
with the digestive tract have also been located in the tegument
(9, 26). These enzymes may function in intracellular protein
turnover or in membrane biogenesis, in addition to playing
roles in the degradation of hemoglobin.
If SmCL1 plays a central role in hemoglobin proteolysis as
the present results indicate, it represents a potential target for
antischistosomal therapies. In view of the sequence differences
between schistosome and human cathepsin L, including diver-
gence in their active site residues (9) and differential sensitivity
to diazomethanes (10), it is feasible that inhibitors that selec-
tively inhibit the schistosome cathepsin L’s could be developed.
Indeed, the potential antischistosomal effects of drugs targeted
at cysteine proteinases has been demonstrated by Wasilewski
et al. (23), using morpholinourea-Phe-Ala-CHN2 and ana-
logues. While these drugs would be inhibitors of both cathep-
sin L and cathepsin B, they produced dramatic reductions in
schistosome worm loads and fecundity in infected mice and
were lethal to cultured schistosomula. Since it is now clear that
schistosome cathepsins, including SmCL1, can be produced in
sufficient quantities in yeast, development of specific inhibitors
of these proteinases can now be addressed.
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